about
Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro.Pathophysiology of limb girdle muscular dystrophy type 2A: hypothesis and new insights into the IkappaBalpha/NF-kappaB survival pathway in skeletal muscle.Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth.The Syk tyrosine kinase localizes to the centrosomes and negatively affects mitotic progression.Reconstruction and signal propagation analysis of the Syk signaling network in breast cancer cells.Catalytically inactive human cathepsin D triggers fibroblast invasive growthThe Syk tyrosine kinase: a new negative regulator in tumor growth and progression.Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.An integrated cell line-based discovery strategy identified follistatin and kallikrein 6 as serum biomarker candidates of breast carcinoma.Adherens Junction and E-Cadherin complex regulation by epithelial polarity.Cell membrane extensions, generated by mechanical constraint, are associated with a sustained lipid raft patching and an increased cell signaling.Phosphoproteomic analysis of Syk kinase signaling in human cancer cells reveals its role in cell-cell adhesion.In vitro invasion assays: phagocytosis of the extracellular matrix.Characterization of centrosomal localization and dynamics of Cdc25C phosphatase in mitosis.Tangeretin inhibits extracellular-signal-regulated kinase (ERK) phosphorylation.Heregulin regulates the actin cytoskeleton and promotes invasive properties in breast cancer cell lines.Action mechanisms of anti-invasive agents.Detection of known and novel ALK fusion transcripts in lung cancer patients using next-generation sequencing approachesA mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells.High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome.Phosphorylated Tyr142 β-catenin localizes to centrosomes and is regulated by Syk.SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells in VitroPathology of tumours produced in syngeneic Fischer rats by fibroblast-like cells before and after transfection with oncogenesPhagocytosis of cross-linked gelatin matrix by human breast carcinoma cells correlates with their invasive capacityFKBP4 connects mTORC2 and PI3K to activate the PDK1/Akt-dependent cell proliferation signaling in breast cancerThe Syk Kinase Promotes Mammary Epithelial Integrity and Inhibits Breast Cancer Invasion by Stabilizing the E-Cadherin/Catenin ComplexThe therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrestPTPN13 induces cell junction stabilization and inhibits mammary tumor invasivenessNetwork Reconstruction and Significant Pathway Extraction Using Phosphoproteomic Data from Cancer Cells
P50
Q31522536-1D1C01F0-95A8-4A37-BC8C-40678C86E999Q34085802-4C66A42C-1B73-4957-8EC7-214366C894A6Q34242086-9ABF7D42-D4E4-4740-9EBC-0C2977CEC5C3Q34472049-46204375-A96D-4449-B07A-CF02753FCDFBQ36312079-D4D27CF7-E5F8-416D-B60C-D4804625C972Q36321336-9253766B-9207-4C73-8023-2429D9D54512Q36380056-FE2E65E8-3ABD-4E91-B51A-017177C21D0FQ37690677-26A58D1F-8BE8-4AB7-9CDF-30789795A1B0Q38771754-421EFB8D-9908-45A4-8D10-AB9B5C46B501Q38827214-A538628A-D467-4922-ACB2-11FF5200B1C8Q39766721-8F295388-C74A-42FD-B6BF-BE62575084E6Q39855642-3CBB0C45-9801-4D57-83C9-47A9F2EB1C57Q39943425-F2F75DFA-32A3-4813-BD88-7F7AE35D2B4CQ39964624-56723C44-9623-42DA-A7F2-5557E86265B6Q40448514-79EBA314-985D-40BC-9ABE-A063670C30C8Q40854076-838870C0-1B06-48E4-BF48-630107FBD567Q41479799-01B8FC82-E08B-4323-A82D-99E5627C7ED9Q42286165-1DCBAEF4-4C7A-4212-8A95-04F457D601E4Q43785805-40DFE592-549D-403F-915B-03EDF0EB5F7FQ47122163-7B8FB85F-1D0C-4A71-9E53-7F33DC2CB6CBQ48134269-19B6AC62-2AF7-4E6E-8D67-1AAA278495B8Q64245695-E2AC8895-0ECD-46EC-B743-74230CBFB5C3Q69037726-45EC53B1-9904-4051-AFE2-150C0395B1F7Q74360944-D32E79F1-33E0-4E27-82F6-75A16AE5D5B1Q90979493-6C2A1BC4-2923-4BFF-BD49-55455F78FBD8Q91816605-2648C066-7B50-4054-8D17-D5D53A8E4C2CQ91973942-1319D844-0215-43D5-9FB8-7F9A40E8D2C1Q92644562-1867ACB3-12CA-41F1-8875-C09F33C4C064Q93030906-AFF3BF3A-6705-4DDB-8D98-C8CD81EB067F
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
P Coopman
@ast
P Coopman
@en
P Coopman
@es
P Coopman
@nl
type
label
P Coopman
@ast
P Coopman
@en
P Coopman
@es
P Coopman
@nl
prefLabel
P Coopman
@ast
P Coopman
@en
P Coopman
@es
P Coopman
@nl
P106
P1153
6602679633
P31
P496
0000-0003-3720-523X